MACROGENICS INC — Director's Dealing 2016

May 27, 2016

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2016-05-18

Reporting Person: Spitznagel Thomas (Vice President, Development)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$7.51	2023-09-17	Common Stock (11985)		Direct
Employee Stock Option (right to buy)	$7.51	2023-09-17	Common Stock (51932)		Direct
Employee Stock Option (right to buy)	$29.68	2024-12-12	Common Stock (16295)		Direct
Employee Stock Option (right to buy)	$29.68	2024-12-12	Common Stock (3705)		Direct
Employee Stock Option (right to buy)	$31.43	2025-12-18	Common Stock (9619)		Direct
Employee Stock Option (right to buy)	$31.43	2025-12-18	Common Stock (3181)		Direct

Footnotes

F1: 12.5% of the shares underlying the grant become (or became) exercisable on the date reflected and an additional 6.25% of the shares underlying the grant become (or became) exercisable on the first day of each three-month period thereafter.